Lung Cancer Clinical Trials

Showing 1941-1960 of 4,288 trials

Risk Communication in African American Smokers

NCT04084561

The study aims to understand the effects of learning about one's genetic risk for lung cancer that is specific to their ancestry. Participants will be given hypothetical personalized genetic risk results and ask to think about how they might respond to such information if they actually received such results.

Lung Cancer

Temple University166 participantsStarted Sep 2018

New York, New York, United States • Philadelphia, Pennsylvania, United States

TERMINATEDPhase 1/2

Survival Prolongation by Rationale Innovative Genomics

NCT03386929

Patients with advanced/metastatic non-small cell lung cancer (NSCLC) with no documented targetable alterations (Epidermal Growth Factor Receptor (EGFR) mutation, Anaplastic Lymphoma Kinase (ALK) translocation, ROS1 mutation if available or MET exon 14 skipping mutation if available) will receive a tri-therapy associating avelumab, axitinib and palbociclib.

Non-small Cell Lung Cancer MetastaticNon-small Cell Lung Cancer Stage IIIB

Worldwide Innovative Network Association15 participantsStarted Nov 2017

La Jolla, California, United States • Sioux Falls, South Dakota, United States • Ramat Gan, Israel +2 more locations

Risk Communication in African American Smokers

Survival Prolongation by Rationale Innovative Genomics

Related Searches

A Study of RC48-ADC in Subjects With Advanced Non-small Cell Lung Cancer

Efficacy of Osimertinib in Patients With Lung Cancer

SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)

Outcome of Patients With Lung Masses Who Are Treated With Radiofrequency Ablation (RFA)

PLAsma Genomic Testing in Patients With Advanced Non-Small Cell Lung Cancer: The PLAN Study

Evaluating the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer (NSCLC)

A Study of Lymph Node Metastatic Pattern Based Incorporating Tumor Location, GGO Components and Size for Non-small Cell Lung Cancer

TEAS for the Treatment of Pain in Bone Metastases of Lung Cancer

Use of Integrated PET/CT as a First Line Staging and Re-staging Technique in Oncologic Patient.

Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent Lorlatinib

Pilot Study of High Risk Lung Cancer Screening

A Study of PRT2527 in Participants With Advanced Solid Tumors

Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma

Optimal Extent of Pulmonary Resection in Clinical Stage IA Non-Small Cell Lung Cancer

Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer

International Lung Screen Trial (ILST)

Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations

Investigating Radiation-Induced Injury to Airways and Pulmonary Vasculature in Lung Stereotactic Ablative Body Radiotherapy (SAbR)